Generate:Biomedicines | Media Center

Blog Posts

Blog Posts October 09, 2025
First-in-Human Results for GB-0669: Durable Neutralization from an AI-Designed Antibody
Blog Posts September 25, 2025
World Lung Day: Laurie Lee on AI, Immunology, and the Future of Respiratory Health

Media Highlights

Media Highlights October 14, 2025
Monoclonal antibody effects persist for 6 months in patients
Media Highlights October 14, 2025
Benchtalk 2025: Generate:Biomedicines’ VP of Informatics Stephen Kottmann describes the investments in technology that ensures only the highest quality data returns back into its models

News Releases

Presentations & Publications

Presentations & Publications October 09, 2025
First-in-Human Study of a First-in-Class AI-Designed Monoclonal Antibody (GB-0669) Against the Conserved SARS-CoV‑2 Spike S2 Stem Helix